In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro antibodies, KIF23 gene – the same tools used by the world’s leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback